DeepChek®-8-plex CoV-2 Genotyping Assay

K-20-CV19-NGS

Description

The DeepChek®-8-plex CoV-2 Genotyping Assay (K-20-CV19-NGS) is intended to be used for Coronavirus (2019-nCoV) Genotyping. It combines target-specific PCR reagents with in vitro diagnostic software both compatible with Next Generation Sequencing platforms.

Methodology

DNA Sequencing • Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

More information on the DeepChek® Assays – Click here
More information on the DeepChek® Software – Click here

Characteristics and performances

Features

Compatibility with Next Generation Sequencing platforms

Any

Intended use

RUO – ISO-9001 manufacturing

Types of samples

Oropharyngeal or nasopharyngeal swab, bronchoalveolar lavage (BAL), sputum, plasma or serum samples

Format

24 samples/kit

Content

RT-PCR & Nested-PCR reagents (enzymes, master mixes, primers, dNTPs...), protocol for NGS sequencing, NGS software analyses for 24 samples through a Cloud access

Workflow

From sample to result in ~30 hours for NGS (depending on the platform)

Compatible extraction methods

Automatic (MagNA Pure Compact Nucleic Acid Isolation Kit I - Roche, Promega - Abbott), Manual (Manual extractions using QIAamp® Viral RNA - Qiagen)...

Data analysis and interpretation software

DeepChek-CoV-2 Software

Pipelines

Genotyping, amino-acid mutations detection, nucleotide changes detection, NGS run quality report, clinical genotyping report...

Uses

Screening Monitoring Quasispecies identification Coronavirus (2019-nCoV) Genotyping Epidemiological studies

Included services

Unlimited updates & upgrades of the software, support, training...

Options

Local servers, historical data import, integration with LIS and HIS, integration with sequencers, automation of the IT workflow, customization...

Overview

 

Ordering information

Product

Reference

DeepChek®-8-plex CoV-2 Genotyping Assay

K-20-CV19-NGS

Downloads

General documentation

MSDS